Kofsky E R, Julia P L, Buckberg G D, Quillen J E, Acar C
Department of Surgery, University of California, Los Angeles School of Medicine.
J Thorac Cardiovasc Surg. 1991 Feb;101(2):350-9.
This study evaluates the role of leukocyte depletion during initial reoxygenation with normal blood and blood cardioplegic reperfusates in limiting reperfusion damage.
Twenty-eight dogs underwent 2 hours of ligation of the left anterior descending coronary artery. The initial reperfusate (37 degrees C) was delivered on total vented bypass to the left anterior descending artery by a calibrated pump via an internal mammary artery graft at 50 mm Hg for 20 minutes. Eight dogs received normal (normokalemic, nonenriched) blood reperfusion (leukocyte count 8000/mm3) and six were reperfused with leukocyte-depleted normal blood (leukocyte count less than 100/mm3). Of 14 dogs reperfused with substrate-enriched (hyperkalemic) blood cardioplegic solution, six received a cardioplegic solution with a leukocyte count less than 100/mm3.
Leukocyte depletion of normal blood reduced reperfusion-induced arrhythmias from 63% to 17% (p less than 0.05). Coronary vascular resistance at initial reperfusion was low and remained low during substrate-enriched blood cardioplegic reperfusion with both normal and reduced leukocyte counts. In contrast, coronary vascular resistance rose 63% with normal blood reperfusion, and this increase was avoided by leukocyte depletion (2.6 versus 4.0 mm Hg x ml/min, p less than 0.05). Coronary vascular resistance after 20 minutes was, however, higher than that with blood cardioplegia with normal or decreased leukocyte counts. Negligible functional recovery followed reperfusion with normal blood and leukocyte-depleted blood (12% and 6% of control systolic shortening). In contrast, substantial segmental recovery followed blood cardioplegic reperfusion (73% systolic shortening, p less than 0.05) but was not improved by leukopheresis (81% systolic shortening). Leukocyte depletion of normal blood reperfusate reduced histochemical damage from 53% to 38% (p less than 0.05), but the least histochemical damage followed blood cardioplegic reperfusion with a normal or reduced leukocyte count (8% or 11%, p less than 0.05).
These findings suggest an important role for leukocytes in reperfusion damage, but reperfusate leukocyte filtration alone is inferior to blood cardioplegic reperfusion. Leukocyte depletion of blood cardioplegic solutions seems unnecessary after only 2 hours of ischemia.
本研究评估在初次复氧时使用正常血液和含血心脏停搏液再灌注时白细胞去除在限制再灌注损伤中的作用。
28只犬接受左前降支冠状动脉结扎2小时。初始再灌注液(37℃)通过校准泵经胸廓内动脉移植物以50mmHg压力在完全开放的旁路下输送至左前降支动脉20分钟。8只犬接受正常(正常血钾、未富集)血液再灌注(白细胞计数8000/mm³),6只犬接受白细胞去除的正常血液再灌注(白细胞计数少于100/mm³)。在14只接受富含底物(高血钾)含血心脏停搏液再灌注的犬中,6只接受白细胞计数少于100/mm³的心脏停搏液。
正常血液白细胞去除使再灌注诱导的心律失常从63%降至17%(p<0.05)。初始再灌注时冠状动脉血管阻力较低,在富含底物的含血心脏停搏液再灌注期间,无论白细胞计数正常还是减少,冠状动脉血管阻力均保持较低。相比之下,正常血液再灌注时冠状动脉血管阻力升高63%,白细胞去除可避免这种升高(2.6对4.0mmHg×ml/min,p<0.05)。然而,20分钟后的冠状动脉血管阻力高于白细胞计数正常或减少的含血心脏停搏液再灌注时的阻力。正常血液和白细胞去除血液再灌注后功能恢复可忽略不计(分别为对照收缩期缩短的12%和6%)。相比之下,含血心脏停搏液再灌注后有显著节段性恢复(收缩期缩短73%,p<0.05),但白细胞去除术未使其改善(收缩期缩短81%)。正常血液再灌注液白细胞去除使组织化学损伤从53%降至38%(p<0.05),但组织化学损伤最小的是白细胞计数正常或减少的含血心脏停搏液再灌注(8%或11%,p<0.05)。
这些发现提示白细胞在再灌注损伤中起重要作用,但单纯再灌注液白细胞过滤不如含血心脏停搏液再灌注。缺血仅2小时后,似乎无需对含血心脏停搏液进行白细胞去除。